[DPHARMA] QoQ TTM Result on 30-Sep-2010 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Nov-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Sep-2010 [#3]
Profit Trend
QoQ- 2.54%
YoY- 7.69%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 134,988 135,625 131,437 129,092 126,816 124,896 123,765 5.97%
PBT 35,995 36,493 35,410 35,413 34,460 35,638 38,215 -3.92%
Tax -6,906 -7,030 -6,741 -7,514 -7,251 -7,252 -7,981 -9.21%
NP 29,089 29,463 28,669 27,899 27,209 28,386 30,234 -2.54%
-
NP to SH 29,089 29,463 28,669 27,899 27,209 28,386 30,234 -2.54%
-
Tax Rate 19.19% 19.26% 19.04% 21.22% 21.04% 20.35% 20.88% -
Total Cost 105,899 106,162 102,768 101,193 99,607 96,510 93,531 8.65%
-
Net Worth 154,198 162,320 156,744 148,494 140,286 146,967 142,996 5.17%
Dividend
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Div 5,014 6,402 6,402 22,910 22,910 16,743 16,743 -55.33%
Div Payout % 17.24% 21.73% 22.33% 82.12% 84.20% 58.98% 55.38% -
Equity
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Net Worth 154,198 162,320 156,744 148,494 140,286 146,967 142,996 5.17%
NOSH 138,917 138,735 138,711 138,779 138,897 138,648 138,831 0.04%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin 21.55% 21.72% 21.81% 21.61% 21.46% 22.73% 24.43% -
ROE 18.86% 18.15% 18.29% 18.79% 19.40% 19.31% 21.14% -
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
RPS 97.17 97.76 94.76 93.02 91.30 90.08 89.15 5.92%
EPS 20.94 21.24 20.67 20.10 19.59 20.47 21.78 -2.59%
DPS 3.61 4.61 4.61 16.50 16.50 12.06 12.06 -55.35%
NAPS 1.11 1.17 1.13 1.07 1.01 1.06 1.03 5.12%
Adjusted Per Share Value based on latest NOSH - 138,779
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
RPS 14.03 14.10 13.66 13.42 13.18 12.98 12.87 5.93%
EPS 3.02 3.06 2.98 2.90 2.83 2.95 3.14 -2.57%
DPS 0.52 0.67 0.67 2.38 2.38 1.74 1.74 -55.39%
NAPS 0.1603 0.1687 0.1629 0.1544 0.1458 0.1528 0.1487 5.14%
Price Multiplier on Financial Quarter End Date
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Date 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 -
Price 2.34 2.35 2.39 2.44 2.45 2.40 2.40 -
P/RPS 2.41 2.40 2.52 2.62 2.68 2.66 2.69 -7.08%
P/EPS 11.17 11.07 11.56 12.14 12.51 11.72 11.02 0.90%
EY 8.95 9.04 8.65 8.24 8.00 8.53 9.07 -0.88%
DY 1.54 1.96 1.93 6.76 6.73 5.03 5.03 -54.67%
P/NAPS 2.11 2.01 2.12 2.28 2.43 2.26 2.33 -6.41%
Price Multiplier on Announcement Date
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Date 18/08/11 25/05/11 23/02/11 26/11/10 24/08/10 25/05/10 23/02/10 -
Price 2.22 2.57 2.45 2.38 2.45 2.38 2.33 -
P/RPS 2.28 2.63 2.59 2.56 2.68 2.64 2.61 -8.64%
P/EPS 10.60 12.10 11.85 11.84 12.51 11.62 10.70 -0.62%
EY 9.43 8.26 8.44 8.45 8.00 8.60 9.35 0.57%
DY 1.63 1.79 1.88 6.93 6.73 5.07 5.18 -53.83%
P/NAPS 2.00 2.20 2.17 2.22 2.43 2.25 2.26 -7.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment